Carrie MacEwen: Champions vision and visibilityBMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h5701 (Published 03 November 2015) Cite this as: BMJ 2015;351:h5701
Carrie MacEwen, president of the Royal College of Ophthalmologists, is a consultant at Ninewells Hospital in Dundee and honorary professor of ophthalmology at the University of Dundee. She stuck her neck out in a BMJ editorial (with Andrew Lotery) by saying that the use of bevacizumab (Avastin) for macular degeneration by the NHS was being held up by “bureaucratic hurdles.” She runs a tertiary referral service for eye movement disorders, is ophthalmology adviser to the Scottish government, and was a founding council member of the Faculty of Sport and Exercise Medicine. She recently tweeted that she loves The Beatles—“a sign of my age, I suppose.”
What was your earliest ambition?
To be a dancer—until I realised that having two left feet was a disadvantage. I decided to be a surgeon, where manual skills are more important.
Who has been your biggest inspiration?
My father has been a wonderful role model all of my life: his enthusiasm for life and his work, in particular, were infectious. A very innovative surgeon, always keen to train and nurture young ophthalmological talent in Scotland.
What was the worst mistake in your career?
Never taking a break! While I have …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial